In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: Mechanisms, key factors, and their implications

Authors
Cho, Yong WooPark, Soo AhHan, Tae HeeSon, Dai HyunPark, Ji SunOh, Seung JunMoon, Dae HyukCho, Kyung-JaAhn, Cheol-HeeByun, YoungroKim, In-SanKwon, Ick ChanKim, Sang Yoon
Issue Date
2007-02
Publisher
ELSEVIER SCI LTD
Citation
BIOMATERIALS, v.28, no.6, pp.1236 - 1247
Abstract
The development of more selective delivery systems for cancer diagnosis and chemotherapy is one of the most important goals of current anticancer research. The purpose of this study is to evaluate various self-assembled nanoparticles as candidates to shuttle radionuclide and/or drugs into tumors and to investigate the mechanisms underlying the tumor targeting with self-assembled nanoparticles. By combining different hydrophobic moieties and hydrophilic polymer backbones, various self-assembled nanoparticles were prepared, and their in vivo distributions in tumor-bearing mice were studied by radionuclide imaging. One type of nanoparticles (fluorescein isothiocyanate-conjugated glycol chitosan (FGC) nanoparticles) exhibited highly selective tumoral localization. Scintigraphic images obtained I day after the intravenous injection of FGC nanoparticles clearly delineated the tumor against adjacent tissues. The mechanisms underlying the tumor targeting with self-assembled nanoparticles were investigated in terms of the physicochemical properties of nanoparticles and tumor microenvironments. FGC nanoparticles were preferentially localized in perivascular regions, implying their extravasation to tumors through the hyperpermeable tumor vasculature. The magnitude and pattern of tumoral distribution of self-assembled nanoparticles were influenced by several key factors -(i) in vivo colloidal stability: nanoparticles should maintain their intact nanostructures in vivo for a long period of time, (ii) particle size, (iii) intracellular uptake of nanoparticle: fast cellular uptake greatly facilitates the tumor targeting, (iv) tumor angiogenesis: pathological angiogenesis permits access of nanoparticles to tumors. We believe that this work can provide insight for the engineering of nanoparticles and be extended to cancer therapy and diagnosis, so as to deliver multiple therapeutic agents and imaging probes at high local concentrations. (c) 2006 Elsevier Ltd. All rights reserved.
Keywords
ENDOTHELIAL-CELLS; ANGIOGENESIS; CHITOSAN; CANCER; ACID; DELIVERY; BIODISTRIBUTION; CONJUGATE; CARRIERS; DOXORUBICIN; ENDOTHELIAL-CELLS; ANGIOGENESIS; CHITOSAN; CANCER; ACID; DELIVERY; BIODISTRIBUTION; CONJUGATE; CARRIERS; DOXORUBICIN; tumor targeting; radionuclide imaging; self-assembled nanoparticles; angiogenesis; drug delivery
ISSN
0142-9612
URI
https://pubs.kist.re.kr/handle/201004/134692
DOI
10.1016/j.biomaterials.2006.10.002
Appears in Collections:
KIST Article > 2007
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE